NCT01586962View on ClinicalTrials.gov

Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Upper Respiratory Infections
Interventions
DRUG

IFF flavor 316 282, Paracetamol, Pseudoephedrine

Single dose syrup containing a warmingflavor IFF 316282 in a syrup containing Paracetamol and pseudoephedrine

Trial Locations (1)

Unknown

Algorithme Pharma, Montreal

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Novartis Consumer Health
All Listed Sponsors
collaborator

Novartis Consumer Health

UNKNOWN

lead

Novartis

INDUSTRY